Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Endogenous peptide hormone, involved in feeding...
Endogenous sphingolipid involved in cell signal...
FAK inhibitor.
Btk inhibitor.
p110β PI3K inhibitor.
Dual RAF/EGFR inhibitor.
Triazole; demethylation inhibitor, NMDA agonist...
Neuroactive mycotoxin produced by Penicillum an...
Alkaloid produced by Streptomyces, DNA cross-li...
Impurity of omeprazole
Endogenous peptide hormone; guanyl cyclase C ag...
c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...
GRP analog, found in Bombina; bombesin and GRP ...
Resveratrol prodrug; potential SIRT1 activator....
Triterpenoid
RET inhibitor.
FAAH inhibitor.
Endogenous neuropeptide, involved in nociceptio...
Triterpene saponin found in species of Panax; 2...
Tripeptide, binds cell surface integrins.